Company: OMQS
Filing Date: 2025-08-22
Form Type: PRE 14A
Source: 0001641172-25-025256
Chunk: 14

Company: OMNIQ Corp.
Filing Date: 2025-08-22
Form: PRE 14A
Chunk 14
---
 Company’s Equity Incentive Plans and ii) certain milestone bonuses as set forth in the Lustgarten Agreement. In the event Mr. Lustgarten’s employment is terminated by Mr. Lustgarten for good reason, or terminated by the Company without cause, Mr. Lustgarten shall be entitled to the greater of (i) the unpaid base salary or (ii) one year’s base salary.

At the sole discretion of our Board, all officers are entitled to merit-based cash and equity bonuses.

| 12 |

Outstanding Equity Awards

The following chart sets forth all outstanding equity awards to Named Executive Officers of the Company as of December 31, 2024. All awards are in the form of options to purchase Common Stock of the Company.

<div align='center'>OUTSTANDING EQUITY AWARDS</div>

|      |     | Number of   |     | Number of     |     |              |     |            |
|      |     | Securities  |     | Securities    |     |              |     |            |
|      |     | underlying  |     | underlying    |     |              |     |            |
|      |     | Unexercised |     | Unexercised   |     | Option       |     | Option     |
|      |     | Options (#) |     | Options (#)   |     | Exercise     |     | Expiration |
| Name |     | Exercisable |     | Unexercisable |     | Price ($/Sh) |     | Date       |

Certain columnar information required by Item 402(p)(2) of Regulation S-K has been omitted for categories where there was no compensation awarded to, or paid to, the named directors during the year ended December 31, 2024.

<div align='center'>EQUITY COMPENSATION PLAN INFORMATION</div>

The following table sets forth the Common Stock of the Company authorized for issuance under the Company’s equity compensation plans as of December 31, 2024.

| Plan category                                          |     | Number of securities to be issued upon exercise of outstanding options, warrants and rights |    |     | Weighted-average exercise price of outstanding options, warrants and rights |    |     | Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a) |    |
|                                                        |     |                                                                                             | -a |     |                                                                             | -b |     |                                                                                                                                            | -c |
| Equity compensation plans approved